about
The miRacle in Pancreatic Cancer by miRNAs: Tiny Angels or Devils in Disease ProgressionOncolytic virotherapy using herpes simplex virus: how far have we come?Emerging therapies for breast cancermiR-124 interacts with the Notch1 signalling pathway and has therapeutic potential against gastric cancerMiR-124-3p/B4GALT1 axis plays an important role in SOCS3-regulated growth and chemo-sensitivity of CML.Bmi-1 regulates stem cell-like properties of gastric cancer cells via modulating miRNAsPotential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma.miR-150 exerts antileukemia activity in vitro and in vivo through regulating genes in multiple pathwaysmicroRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.Nuclear microRNAs in normal hemopoiesis and cancerDecreased expression of miR-939 contributes to chemoresistance and metastasis of gastric cancer via dysregulation of SLC34A2 and Raf/MEK/ERK pathway.Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer.miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1.miRNAs in acute myeloid leukemia.The leukemogenic fusion gene MLL-AF9 alters microRNA expression pattern and inhibits monoblastic differentiation via miR-511 repression.Editorial: Molecular Function and Regulation of Non-coding RNAs in Multifactorial Diseases.Oncogenic long noncoding RNA landscape in breast cancer.TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5.Exploiting microRNAs As Cancer Therapeutics.Translational research and symptom management in oncology nursing.Mechanisms of resistance to third-generation EGFR tyrosine kinase inhibitors.T-ALL and thymocytes: a message of noncoding RNAsMicroRNA-429 inhibits gastric cancer migration and invasion through the downregulation of specificity protein 1.Low expression of miR-1469 predicts disease progression and unfavorable post-surgical clinical outcomes in patients with esophageal squamous cell cancer.Mel-18 negatively regulates stem cell-like properties through downregulation of miR-21 in gastric cancer.Piceatannol induced apoptosis through up-regulation of microRNA-181a in melanoma cells.PDGFR-modulated miR-23b cluster and miR-125a-5p suppress lung tumorigenesis by targeting multiple components of KRAS and NF-kB pathways.miR-21 modulates the effect of EZH2 on the biological behavior of human lung cancer stem cells in vitro.MicroRNA-590-5p regulates cell viability, apoptosis, migration and invasion of renal cell carcinoma cell lines through targeting ARHGAP24.Diagnostic and prognostic values of serum exosomal microRNA-21 in children with hepatoblastoma: a Chinese population-based study.An innovative mesothelioma treatment based on miR-16 mimic loaded EGFR targeted minicells (TargomiRs).Effects of miR‑138‑5p and miR‑204‑5p on the migration and proliferation of gastric cancer cells by targeting EGFR.miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
P2860
Q26744831-16C4F91D-EE0E-4712-95B3-D5A6FEA5FE63Q26862461-F6084E4E-870C-4B70-A25B-70C99143AAE4Q33617949-6956D533-A1A6-47B7-9157-DDADFD0BD85BQ36504303-B3F9F4F3-0BEA-4ADD-997F-E4E3FB45AA07Q37170170-8DE495DE-9E50-430C-B215-833C36444F47Q37267862-0321E4A4-C645-42F7-BD1C-83B2C52DB2B5Q37327618-1897EF74-1AAE-4A82-87C9-29D55B8D56D3Q37330835-BCF17EA5-402A-45F9-8A5C-C5439CFFFEBCQ37362485-5441C0F7-1582-4B52-BA73-8B70DD34F0E7Q37565996-6DF45A34-21D6-4F4B-9329-BBBD45D4FD43Q37602508-C3EC1583-72D3-4026-A488-AC8743E569A5Q37649185-7D834EFD-60E1-4CBC-9DDD-9CF1B107285FQ37694872-B4F982AC-68D2-4C89-9CAD-0E4B10B06607Q37709531-19B04469-A9DE-457A-B873-A401E776EB20Q38452459-42A1926C-EB33-42C0-9992-EA1376FA5D5AQ38563105-97A24B68-E2F6-40A5-B584-B76BF1DF9876Q38664338-3D129EE9-A1EE-4287-BAFA-088B0AF1A42CQ38714446-73A40B19-69C1-475D-A456-7E6A80DB91D6Q38733764-63B10CF3-8C31-45D6-A377-31A69D398B1DQ38764098-64B1A40B-48EA-482E-9C58-14A4A77EA7C3Q38845822-FCAF8DCF-CA86-4E31-90D3-E3C100B2F5DDQ38988061-0B98B3A1-BCFA-4BDE-B4C9-3B9FFB7CB1D2Q39166891-F65D9B3C-7A4A-4B51-ACB9-7D8B31DDB4FBQ41779465-EBD1372D-8FF7-4ED3-80A8-98AB14ADDDB3Q41980198-386C9B1F-06A9-4A14-81E9-9B9EA16BB511Q42319926-BE2AF770-7031-4FD5-8F6B-1D886F902998Q42690681-930D2084-6E11-4672-9F8D-2A7AFBFD2D9CQ46791030-E1D0624A-3582-4EA0-BC03-48A07E5FB32AQ47093759-5FDD5DEF-1550-4773-91B6-DCBA87B3EDC1Q47667730-BA93FB1D-CFE9-4CBE-A5F6-47AB19168193Q51820947-F2D0661A-9F27-4E9D-8A11-6693AB147978Q52659191-BE77F191-C965-4A9F-8C5D-F9CEF0F16F7AQ55113730-8A11DD45-01CD-4043-8AC7-EF6FC392C792Q55413938-F5EDAE98-FEFC-4756-80EC-986AB793D445
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MiRNA-based therapeutic intervention of cancer.
@en
type
label
MiRNA-based therapeutic intervention of cancer.
@en
prefLabel
MiRNA-based therapeutic intervention of cancer.
@en
P2093
P2860
P1476
MiRNA-based therapeutic intervention of cancer.
@en
P2093
Michela Garofalo
Peter Magee
Srivatsava Naidu
P2860
P2888
P356
10.1186/S13045-015-0162-0
P5008
P577
2015-06-11T00:00:00Z
P5875
P6179
1028188257